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Abstract
Background: Placental defects in somatic cell nuclear transfer (SCNT) are a major cause of complications during
pregnancy. One of the most critical factors for the success of SCNT is the successful epigenetic reprogramming of
donor cells. Recently, it was reported that the placental weight in mice cloned with the aggregated SCNT method
was significantly reduced. Here, we examine the profile of abnormal gene expression using microarray technology
in both regular SCNT and aggregated SCNT placentas as well as in vivo fertilization placentas. One SCNT embryo
was aggregated with two 2 to 4 -cell stage tetraploid embryos from B6D2F1 mice (C57BL/6 × DBA/2).
Results: In SCNT placentas, 206 (1.6%) of the 12,816 genes probed were either up-regulated or down-regulated by
more than two-fold. However, 52 genes (0.4%) showed differential expression in aggregated SCNT placentas
compared to that in controls. In comparison of both types of SCNT placentas with the controls, 33 (92%) out of 36
genes were found to be up-regulated (>2-fold) in SCNT placentas. Among 36 genes, 13 (36%) genes were up-
regulated in the aggregated SCNT placentas. Eighty-five genes were down-regulated in SCNT placentas compared
with the controls. However, only 9 (about 10.5%) genes were down-regulated in the aggregated SCNT placentas. Of
the 34 genes known as imprinted genes, expression was lower in SCNT placentas than that in the controls. Thus,
these genes may be the cause of placentomegaly in mice produced post SCNT.
Conclusions: These results suggest that placentomegaly in the SCNT placentas was probably caused by abnormal
expression of multiple genes. Taken together, these results suggest that abnormal gene expression in cloned
placentas was reduced in a genome-wide manner using the aggregation method with tetraploid embryos.
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Background
Somatic cell nuclear transfer (SCNT) in animals has the
potential to be used in a wide range of applications such
as species preservation, livestock propagation, and gene
targeting [1]. However, this technology is inefficient and
results in various abnormalities, leading to high preg-
nancy losses and neonatal deaths [2]. Although the
cloned fetuses attain full term, placentomegaly is a com-
mon phenotype observed in cloned animals, irrespective
of donor cell type and strain [3–5]. Placentomegaly
mainly seems to arise from an abnormally expanded
spongiotrophoblast layer with an increased number of
glycogen cells, and irregular borderlines between the
labyrinthine and spongiotrophoblast layers [6]. Interest-
ingly, the same pattern of placentomegaly was also
observed in interspecies hybridization [7, 8], during
sperm injection following introduction of somatic cell
cytoplasm into an oocyte [9], and in knockout mice with
imprinting genes such as EsxI [10], Ipl [11], and H19
[12]. Thus, reduction in placental weight is necessary to
obtain live and normal fetuses in SCNT.
Several global gene expression analyses using microar-
rays of more than 10,000 genes were conducted on
samples from neonatal placenta to reveal a cluster of
abnormally expressed genes [13–15] in the placentas of
cloned mice. Of those SCNT-derived embryos that
develop to full term, up to 40% have large offspring
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syndrome (LOS), characterized by hydrops of the fetus,
lethargy, and respiratory distress [15–17]. Aggregation of
embryonic stem (ES) cells with tetraploid blastocysts has
been successfully conducted in mice [18, 19], and chimeric
monkeys were produced by the aggregation of 4-cell em-
bryos [20]. We also reported that aggregated SCNT
significantly reduced placental weight of cloned mice and
improved SCNT efficiency [5]. However, the differences in
the genetic pattern of aggregated SCNT embryos and
SCNT embryos are not clearly identified. It is therefore
very important to analyze the differences in gene expres-
sion between the two types of SCNT embryos. In addition,
these results will offer important information in solving
the problem of lethality in cloned mice production.
In this study, the mRNA expression profiles of SCNT
and aggregated SCNT placentas were analyzed using
microarray technology. Many genes were found to be
differentially expressed between the SCNT and aggre-
gated SCNT placenta. These results further provide
evidence supporting the importance of placental abnor-
malities in cloned animal production.
Methods
Placental samples
B6D2F1 mice (C57BL6 ×DBA/2) were used to prepare
oocytes and cumulus cells. Two-celled embryos were elec-
trofused to produce one-cell tetraploid embryos. Tetra-
ploid embryos were then aggregated with SCNT embryos.
One embryo was aggregated with two 2 to 4 cell tetraploid
embryos. Detailed methods are described in a previous
report [5]. MII oocytes were collected from 6 to 12-week-
old females (69 mice). Embryos electrofused were trans-
ferred to the foster mothers (47 mice). All recipient
females were euthanized at 19.5 dpc and placentas were
obtained. Finally, we produced a total of 36 clone mice
and placental samples. The protocol was approved by the
Committee on Ethics of Animal Experiments at the
Hankyong National University (Permit Number: 2014–4).
Microarray analysis
Total RNA was extracted from five SCNT placentas, six
aggregated SCNT placentas, and four controls by using
TRIzol reagent (Invitrogen Life Technologies, Carlsbad,
USA) and purified using RNeasy columns (Qiagen, Valencia,
USA), according to the manufacturers’ protocols.
Labeling and purification
Total RNA was amplified and purified using the Ambion
Illumina RNA amplification kit (Ambion, Austin, USA)
to yield biotinylated cRNA, according to the manufac-
turer’s instructions. Briefly, 550 ng of total RNA was
reverse-transcribed to cDNA using a T7 oligo(dT)
primer. Second-strand cDNA was synthesized, tran-
scribed in vitro, and labeled with biotin-NTP.
Hybridization and data export
The labeled cRNA samples (0.75 μg) were hybridized to
the Illumina MouseRef-8 v2 expression BeadChip
(Illumina, Inc., San Diego, USA) for 16–18 h at 58 °C,
according to the manufacturer’s instructions. Detection
of the array signals was carried out using Amersham
Fluorolink Streptavidin-Cy3 (GE Healthcare Bio-Sciences,
Little Chalfont, UK), following the bead array manual.
Arrays were scanned with an Illumina bead array reader
confocal scanner. Array data analysis was performed using
Illumina Genome Studio v.2009.2 (Gene Expression
Module v.1.5.4).
Raw data preparation and statistical analysis
The raw data were extracted using the software provided
by the manufacturer (Illumina Genome Studio v.2009.2).
The array data were filtered using a detection p-value <
0.05 (a signal value higher than that of the background
was required to obtain a detection p-value < 0.05). The
selected gene signal value was logarithmically trans-
formed and normalized. Comparative analysis between 2
groups was carried out by p-value evaluation, using the
local-pooled-error test (adjusted Benjamini-Hochberg
false discovery rate controlled by 5%) and fold-change.
Biological ontology-based analysis was performed using
the Panther database (http://www.pantherdb.org). In
addition to these statistical criteria, genes whose expres-
sion differed by more than two-fold were considered
differentially expressed between the two groups.
Quantitative real-time PCR (qRT-PCR)
To validate the microarray data, 12 genes (viz., Plac1,
Slc38a4, Rprml, Pla2g4f, Pla2g4d, Hsd17β7, Hmox1,
Chac1, Car2, Slpi, Nrn1l, and H19) from different cat-
egories were chosen for qRT-PCR analyses. The expres-
sion of these genes was either up- and down-regulated
by more than two-fold. qRT-PCR was performed with
the same placenta used in the microarray analyses.
Primer sequences are outlined in Additional file 1: Table
S1 along with the primer annealing temperatures. The
primers were designed with the help of Primer 3 software
(www.bioneer.co.kr/products/Oligo/CustomOligonucleo-
tides-overview.aspx). Gene expression was analyzed from
5 SCNT placentas and 3 control placentas. The β-actin
(ACTB) gene was used as the endogenous control, and
the results of the analysis were calculated by using the 2-
ΔΔCT method for quantitative relationships.
Results
Abnormal gene expression profiles between SCNT,
aggregated SCNT, and control placentas
The mouse placentas derived from SCNT, aggregated
SCNT, and in vivo fertilized controls were analyzed
for their global gene expression patterns using the
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microarray method. The placental weight of the control,
aggregated SCNT, and SCNT was 0.147 g (n = 8),
0.215 g (n = 9), and 0.287 (n = 27), respectively, as previ-
ously described [5].
Gene transcription levels were detected in the micro-
array analysis using 12,816 gene probes. Genes showing
>2-fold difference in expression were identified for 15
placentas (SCNT, 5; aggregation SCNT, 6; control 4).
Figure 1a shows the gene expression differences between
control and SCNT placentas. The expression of 206
(1.6%) of 12,816 genes was found to differ by at least
two-fold between the SCNT placentas and the controls.
Similarly, 159 genes showed different expression
between the SCNT placentas and the aggregated SCNT
placentas (Fig. 1b). However, 52 (0.4%) genes showed
difference (>2-fold) in expression between the aggre-
gated SCNT placentas and the controls (Fig. 1c).
Co-up- and down-regulated genes in SCNT and aggre-
gated SCNT placentas compared with controls
Many of the differentially expressed gene probes were
common to the two types of clones, whereas some were
deregulated either in SCNT placentas or in the aggre-
gated SCNT placentas alone. Of the 36 genes up-regu-
lated in SCNT placentas, 10 (27.7%) were commonly
up-regulated in the aggregated SCNT placenta group.
Ten genes [Pla2g4f, Car2, Tekt1 (probe1), Tekt1
(probe2), Pla2g4d, Rprm1, Hsd17b7, Hic1, Hmox1, and
Coll15a1] were up-regulated (>2-fold) in both SCNT
and aggregated SCNT placentas (Table 1). However,
three genes (Abcc10, Prss22, and Slc22a18) were only
up-regulated in the aggregated SCNT placentas. The
number of genes showing >2-fold up-regulation in the
SCNT placentas was decreased by 33% (from 39 to 13)
in the placentas obtained by aggregated SCNT.th=tlb=
In Table 2, we have identified the genes showing sig-
nificant downregulation (>2-fold) in the SCNT, aggre-
gated SCNT, and control placentas. Eighty-five genes
were found to be downregulated in SCNT placentas in
comparison with their expression in the controls. In
contrast, 16 of these genes (18%) (Sftpd, Tph,
2010109103Rik, Cbx7, Osta, Serpina10, Macb, Fcgrt,
Bex2, 84304C8G22Rik, Acox2, Vdr, Dab2, Cfi, Ltf, and
Dab2) were upregulated in aggregated SCNT placentas
in comparison with their expression in the controls. Five
of the 85 genes (6%) (Inhba, Chac1, Nrn11, Tnfrsf11b,
and Slpi) were down-regulated (>2-fold) in both types of
SCNT placentas compared to their expression in the
controls (Table 2). Four genes (Nppb, 1200015F23Rik,
Uap1, and Ctsm) were only downregulated (>2-fold) in
the aggregated SCNT placentas. These abnormalities in
gene expression were significantly reduced with the use
of the aggregated SCNT method.
Up-and down-regulated genes in SCNT and aggregated
SCNT placentas
We next compared the expression patterns of the up-
regulated (>2-fold) genes between SCNT and aggregated
SCNT placentas. Twenty-one genes showed higher
expression in SCNT placentas than in aggregated SCNT
placentas. Four of these genes (19%; Ermap, Prl4a1,
Sbsn, and Serpinb9d) also showed >2-fold higher expres-
sion in the SCNT placentas than in the controls.
Additional seven genes (30%; Atf4, Atp6v1d, Fmr1nb,
Gnaq, Riok1, Tomm22, and Zfp330) showed >2-fold
lower expression in the aggregated SCNT placentas than
a b c
Fig. 1 Hierarchical cluster of expression profiles in placentas of both types of cloned mice and the in vivo fertilization placenta (control). a A
cluster of 206 genes between the control and the SCNT placentas, (b) a cluster of 159 genes between aggregated SCNT and SCNT placentas, and
(c) a cluster of 52 genes between aggregated SCNT and control placentas. Expression of more than 2-fold difference is indicated by increasing
red intensity and green indicates reduced expression. SCNT, con = control
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in the controls (Table 3). We also analyzed the expres-
sion patterns of the down-regulated (p<0.05 and >2-fold)
genes between both SCNT groups. Of the 102 genes that
showed lower expression in the SCNT placentas than in
the aggregated SCNT group, 53 (51%) had even lower
expression than that observed in the controls. However,
four genes were up-regulated and one gene (Slpi) was
down-regulated in the aggregated SCNT placentas com-
pared with that in the controls (Table 4).
Biological process and functional prediction of the
differentially expressed genes
We further analyzed the data to obtain more insights into
the biological processes and functions of the differentially
expressed genes. The distribution of 206 genes that
showed differential expression (of at least 2-fold) between
the SCNT placentas and the controls, as well as their dis-
tribution in different gene ontology (GO) categories, is
given in Additional file 2: Figure S1 and Additional file 3:
Figure S2. GO-based analysis was performed using the
Panther database (http://www.pantherdb.org). The GO
terms under the category “biological process” that were
most represented (>7%) in the SCNT placentas included
“signal transduction (14%),” “immunity and defense
(10%),” “transport (8%),” “protein metabolism and modifi-
cation (8%),” and “developmental processes (7%).” In
particular, the proportion of genes under “biological
process unclassified” was 12% (Additional file 2: Figure
S1). Under the category of “molecular function,” genes
were classified into 27 categories by GO, the most repre-
sented ones being those for “select-regulatory molecule
(9%),” “signaling molecule (9%),” “transporter (7%),” and
“oxidoreductase (7%).” Sixteen percent of genes were
categorized under “molecular function unclassified”
(Additional file 3: Figure S2). The number of
classified genes constitutes the number of categories
calculated after excluding the overlapping ones.
Imprinting gene expression in the clones
Next, we focused on the expression profiles of imprinted
genes in placentas. Of the 34 imprinted genes identified,
none showed differences (>2-fold) in expression between
the SCNT and aggregated SCNT placentas. Of these 34
genes, two Slc22a18; Slc38a4 showed higher expression
(>2-fold) in the aggregated SCNT placenta than in the
controls. Conversely, Igfbp6 was down-regulated (>2-
fold) in the SCNT placentas than in the controls. Six
genes Ppp1r9a, Tssc4, Ascl2, Cd81, Pon2, and Slc22a2
were placenta-specific imprinted genes that are
expressed on the maternal allele in mice and humans.
All these six genes were similarly expressed between the
SCNT, aggregated SCNT, and control placentas. Most of
the imprinted genes showed lower expression in SCNT
placentas than in the controls (Table 5).
Table 1 Genes that were up-regulated (fold change) in SCNT
placentas versus in control placentas




Significantly elevated in NT alone
Tiam1 NM_009384.2 2.32* 1.91
Dao1 NM_010018.2 2.36* 1.88
Mmp15 NM_008609.3 2.27* 1.78
Cxcl1 NM_008176.1 2.42* 1.84
Aldh1a3 NM_053080.2 2.08* 1.54
E130203B14Rik NM_178791.4 2.05** 1.50
Cdx2 NM_007673.3 2.74* 1.98
Plac1 NM_019538.3 2.73** 1.86
Slc38a4 NM_027052.3 2.32** 1.55
Irs3 NM_010571.3 2.23* 1.46
Ldoc1 NM_001018087.1 2.78* 1.78
Gna14 NM_008137.3 3.05** 1.87
Galk1 NM_016905.2 2.32* 1.40
Serpinb9d NM_011460.1 2.05* 1.23
Prl7c1 NM_026206.2 3.22** 1.89
Prl2c1 NM_001045532.1 2.40** 1.36
Ms4a10 NM_023529.2 2.64* 1.49
Sbsn NM_172205.3 3.07** 1.64
Prl2c5 NM_181852.1 2.51* 1.33
Sbsn NM_172205.3 3.32* 1.63
Serpinb9d NM_011460.1 3.03** 1.46
Prl4a1 NM_011165.3 2.69** 1.26
Ghrh NM_010285.2 2.15* −1.06
Ada (probe 1) NM_007398.3 2.86** 1.54
Ada (probe 2) NM_007398.3 3.11** 1.92
Ermap NM_013848.1 2.84* 1.12
Col15a1 NM_009928.3 2.70* 2.59
Hmox1 NM_010442.1 2.73** 2.35
Rprml NM_001033212.1 3.25** 2.69
Hsd17b7 NM_010476.3 3.24** 2.45
Hic1 NM_010430.2 3.02* 2.25
Pla2g4f NM_001024145.1 4.10** 2.69
Pla2g4d NM_001024137.1 3.70** 2.32
Tekt1 (probe 1) NM_011569.2 3.40* 2.05
Tekt1 (probe 2) NM_011569.2 3.90* 2.26
Car2 NM_009801.3 3.95* 2.09
Significantly elevated in aggregation
Abcc10 NM_170680.2 1.01 2.96*
Prss22 NM_133731.1 −1.11 2.44*
Slc22a18 NM_008767.2 1.32 2.95*
SCNT somatic cell nuclear transfer
*Significantly elevated in NT alone
*p < 0.05; **p < 0.01
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Table 2 Genes that were down-regulated (fold change) in SCNT placentas versus in control placentas








1300017J02Rik NM_027918.1 −2.67** −1.34 Cbx7 NM_144811.3 −3.10** 1.12
Ly6g6c NM_023463.3 −3.82** −1.92 Osta NM_145932.3 −2.88* 1.18
Pcyox1 NM_025823 −2.16** −1.10 Entpd2 NM_009849.1 −3.64** −1.10
Lamb3 NM_008484.2 −2.94* −1.53 Bex4 NM_212457.1 −3.50** −1.07
Ang NM_007447.2 −2.26* −1.20 Serpina10 NM_144834.3 −2.39* 1.36
Bmp4 NM_007554.2 −2.59** −1.42 Fga NM_010196.1 −3.51** −1.10
LOC100046120 XM_001475611.1 −2.62** −1.51 1700045I19Rik NM_028842.1 −3.47** −1.11
Aqp8 NM_007474.1 −2.32** −1.36 Fga NM_010196.2 −3.47** −1.12
Heph NM_010417.1 −2.52* −1.51 BC040758 NM_001033364.1 −3.34** −1.12
Serping1 NM_009776.1 −2.35** −1.43 Maob NM_172778.1 −2.95* 1.01
Doxl2 NM_001029987.1 −2.18** −1.33 BC040758 NM_001033364.1 −3.34** −1.12
Saa3 NM_011315.3 −2.95** −1.79 Fcgrt NM_010189.1 −2.75** 1.07
Aqp8 NM_007474.1 −2.19** −1.34 Gdpd3 NM_024228.2 −3.60** −1.23
Klk4 NM_019928.1 −2.79** −1.72 Cldn2 NM_016675.3 −2.93** −1.01
Serpind1 NM_008223.2 −2.67* −1.67 Psca NM_028216.1 −4.43** −1.53
Abp1 NM_029638.1 −2.06** −1.33 1600015I10Rik NM_001081273.1 −4.64** −1.61
Krt14 NM_016958.1 −2.11* −1.42 Bex2 XM_977338.1 −2.52* 1.14
Scg5 NM_009162.3 −2.77* −1.95 Apom NM_018816.1 −3.27** −1.16
Mustn1 NM_181390.2 −2.05* −1.65 8430408G22Rik NM_145980.1 −2.12* 1.31
Tacstd2 NM_020047.3 −2.07** −1.71 Acox2 NM_053115.1 −2.53** 1.08
Sfrp5 NM_018780.2 −2.02** −1.88 Spp2 NM_029269.1 −2.91** −1.06
Sftpd NM_009160.1 −4.14** 1.13 Vdr NM_009504.3 −2.19* 1.21
Tph1 NM_009414.2 −2.65* 1.59 Itih3 NM_008407.1 −2.64* −1.00
2010109I03Rik NM_025929.2 −2.75** 1.47 Spink3 NM_009258.2 −2.81* −1.08
Amn NM_033603.2 −4.03** −1.14 Apoa2 NM_013474.1 −2.77* −1.07








Significantly reduced in NT Significantly reduced in NT
Tfrc NM_011638.3 −3.08** −1.20 C3 NM_009778.1 −2.23* −1.06
Kng1 NM_023125.2 −3.07* −1.20 Igfbp6 NM_008344.2 −3.64** −1.76
Fcgr3 NM_010188.4 −2.56* −1.02 Popdc3 NM_024286.1 −3.68** −1.79
Dab2 NM_001008702.1 −2.34** 1.06 Muc13 NM_010739.1 −2.09** −1.03
Gldc NM_138595.1 −2.66** −1.08 Lcn2 NM_008491.1 −2.42* −1.20
Serpina1b NM_009244.4 −2.80** −1.14 Inhba NM_008380.1 −2.81** −2.25
Tfrc NM_011638.3 −2.87** −1.18 Chac1 NM_026929.3 −2.27* −2.09
Cfi NM_007686.2 −2.20* 1.10 Nrn1l NM_175024.3 −2.49* −2.49*
Ltf NM_008522.3 −2.30** 1.05 Tnfrsf11b NM_008764.3 −2.15* −2.30
Gpc3 NM_016697.2 −2.50* −1.05 Slpi NM_011414.2 −4.56** −2.09
Mgst1 NM_019946.3 −2.51* −1.06
Fgg NM_133862.1 −2.95** −1.25 Significantly reduced in aggregation
Nr1h4 NM_009108.1 −3.16* −1.35 Nppb NM_008726.3 −1.46 −3.14**
Dab2 NM_023118.1 −2.31 1.01 1200015F23Rik NM_001033136.2 −1.00 −2.71*
Kng1 NM_023125.2 −2.87 −1.24 Uap1 NM_133806.4 1.27 −2.72**
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Gene expression analysis by qRT- PCR
To validate our microarray analysis, we performed qRT-
PCR analysis for the 12 genes identified (Fig. 2). With
regard to the down-regulated genes that were identified
by microarray in SCNT placentas, three Chac1, Slpi, and
Nrn1l were confirmed to be down-regulated in the
SCNT placentas by qRT-PCR. Eight genes Plac1,
Slc38a4, Rprml, Pla2g4f, Pla2g4d, Hsd17β7, Hmox1, and
Car2 were identified as up-regulated by >2-fold in the
SCNT placentas. Six of these genes Slc38a4, Rprml,
Pla2g4f, Pla2g4d, Hsd17b7, and Car2 were confirmed to
be up-regulated by qRT-PCR (Table 6). The fold change
in expression of H19, a known imprinting gene, was
found to be 1.1 in the microarray analysis indicating,
that its expression level was similar in the SCNT placen-
tas and controls, and confirming that the results of
Table 2 Genes that were down-regulated (fold change) in SCNT placentas versus in control placentas (Continued)
Slc7a9(prob1) NM_021291.1 −3.04 −1.34 Ctsm NM_022326.3 1.12 −4.82**
Slc7a9(prob2) NM_021291.1 −2.82 −1.24
Irf6 NM_016851.2 −2.43 −1.08
Trf NM_133977.2 −2.37 −1.08
Serpina1d NM_009246.3 −2.59 −1.19
Sema4a NM_013658.2 −2.60 −1.20
Serpina1b NM_009244.4 −2.62 −1.21
Gipc2 NM_016867.1 −2.56 −1.19
Kng2 NM_201375.1 −2.59 −1.20
Slc27a2 NM_011978.2 −2.96 −1.40
*Significantly reduced in NT alone, *p < 0.05; **p < 0.01
Table 3 Comparison of the genes that were up-regulated (fold change) in SCNT placentas versus in aggregated SCNT placentas
Gene symbol Accession No. Folder Δ SCNT/Agg Folder Δ SCNT/Con Folder Δ Agg/Con
Cmas NM_009908.1 3.15** 1.85** −1.70
Ermap NM_013848.1 2.53** 2.84* 1.12
Prl2a1 NM_019991.1 2.22** 1.30* −1.70
Prl4a1 NM_011165.3 2.13** 2.69** 1.26
Sbsn NM_172205.3 2.03* 3.32** 1.63
Serpinb9d NM_011460.1 2.08** 3.03** 1.46
2310039H08Rik NM_025966.3 2.11* 1.28 −1.65
Gpn2 NM_133884.1 2.14* 1.14 −1.88
H2-Q5 NM_010393.1 2.10** 1.45 −1.45
Matn1 NM_010769.1 2.30* 1.81 −1.27
Mlycd NM_019966.2 2.08** 1.19 −1.74
Pacsin1 NM_011861.2 2.20* 1.28 −1.71
Prcp NM_028243.2 2.12** 1.37 −1.55
Stab2 NM_138673.2 2.03* 1.32 −1.54
Atf4 NM_009716.2 2.42* 1.02 −2.36
Atp6v1d NM_023721.2 2.43** −1.01 −2.46
Fmr1nb NM_174993.1 2.35** 1.14 −2.07
Gnaq NM_008139.5 2.75** 1.23 −2.25
Riok1 NM_024242.2 2.37** 1.08 −2.19
Tomm22 NM_172609.3 2.35** 1.04 −2.26
Zfp330 NM_145600.1 2.58** 1.14 −2.26
Significantly elevated in SCNT
*p < 0.05; **p < 0.01
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Table 4 Comparison of the genes that were down-regulated (fold change) in SCNT placentas versus in aggregated SCNT placentas
Gene symbol Accession No. Folder Δ SCNT/Agg Folder Δ SCNT/Con Folder Δ Agg/Con
C6 NM_016704.1 −2.05** −1.75* 1.17
5033414D02Rik NM_026362.1 −2.04** −1.86* 1.10
Sftpd NM_009160.1 −4.68** −4.14** 1.13
Tph1 NM_009414.2 −4.20** −2.65* 1.59
2010109I03Rik NM_025929.2 −4.04** −2.75** 1.47
Amn NM_033603.2 −3.55** −4.03** −1.14
Cbx7 NM_144811.3 −3.46** −3.10** 1.12
Osta NM_145932.3 −3.40** −2.88* 1.18
Entpd2 NM_009849.1 −3.30** −3.64** −1.10
Bex4 NM_212457.1 −3.26** −3.50** −1.07
Serpina10 NM_144834.3 −3.25** −2.39* 1.36
Fga NM_010196.1 −3.18** −3.51** −1.10
1700045I19Rik NM_028842.1 −3.13** −3.47** −1.11
Fga NM_010196.2 −3.10** −3.47** −1.12
BC040758 NM_001033364.1 −2.99** −3.34** −1.12
Maob NM_172778.1 −2.99* −2.95* 1.01
BC040758 NM_001033364.1 −2.97** −3.34* −1.12
Fcgrt NM_010189.1 −2.94** −2.75** 1.07
Cldn2 NM_016675.3 −2.91** −2.93** −1.01
Psca NM_028216.1 −2.90** −4.43** −1.53
1600015I10Rik NM_001081273.1 −2.89** −4.64** −1.61
Bex2 XM_977338.1 −2.88** −2.52* 1.14
Apom NM_018816.1 −2.81** −3.27** −1.16
8430408G22Rik NM_145980.1 −2.77** −2.12* 1.31
Acox2 NM_053115.1 −2.74** −2.53** 1.08
Spp2 NM_029269.1 −2.74** −2.91** −1.06
Muc13 NM_010739.1 −2.03* −2.09** −1.03
Lcn2 NM_008491.1 −2.01* −2.42** −1.20
Slpi NM_011414.2 −2.18** −4.56** −2.09
Aig1 NM_025446.1 −2.81** −1.09 2.57
Wfdc2 NM_026323.2 −2.02* −1.01 2.00
Snca NM_009221.2 −2.86** −1.56 1.84
Eraf NM_133245.1 −2.84** −1.61 1.77
Snca NM_009221.2 −2.66** −1.42 1.87
Slco2b1 NM_175316.3 −2.64** −1.88 1.41
Hpx NM_017371.1 −2.52* −1.70 1.49
1810007E14Rik NM_025308.1 −2.52** −1.66 1.52
Slc4a1 NM_011403.1 −2.49** −1.48 1.68
Alas2 NM_009653.1 −2.46** −1.41 1.75
Ctsh NM_007801.1 −2.43** −1.97 1.24
Ttr NM_013697.3 −2.34* −1.65 1.42
Dnmt3l NM_019448.2 −2.31** −1.36 1.69
Abhd14b NM_029631.2 −2.25* −1.77 1.27
Cish NM_009895.3 −2.22* −1.99 1.12
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Table 4 Comparison of the genes that were down-regulated (fold change) in SCNT placentas versus in aggregated SCNT placentas
(Continued)
Vdr NM_009504.2 −2.22** −1.89 1.17
Dnmt3l NM_001081695.1 −2.21** −1.40 1.58
Gstm1 NM_010358.4 −2.19* −1.67 1.31
Magi1 NM_001029850.2 −2.18** −1.21 1.80
Upk3b NM_175309.3 −2.16* −1.70 1.27
Clic6 NM_172469.3 −2.16* −1.73 1.24
LOC100044204 XM_001471696.1 −2.14** −1.88 1.14
Igfbp2 NM_008342.2 −2.12** −1.65 1.29
Vdr NM_009504.3 −2.65** −2.19* 1.21
Itih3 NM_008407.1 −2.63** −2.64* −1.00
Apoa2 NM_013474.1 −2.59** −2.77* −1.07
Tfrc NM_011638.3 −2.56** −3.08** −1.20
Kng1 NM_023125.2 −2.56** −3.07* −1.20
Fcgr3 NM_010188.4 −2.52** −2.56* −1.02
Dab2 NM_001008702.1 −2.48** −2.34* 1.06
Gldc NM_138595.1 −2.47* −2.66** −1.08
Serpina1b NM_009244.4 −2.45** −2.80** −1.14
Tfrc NM_011638.3 −2.44** −2.87** −1.18
Cfi NM_007686.2 −2.43** −2.20* 1.10
Ltf NM_008522.3 −2.40** −2.30** 1.05
Gpc3 NM_016697.2 −2.38** −2.50* −1.05
Mgst1 NM_019946.3 −2.37** −2.51* −1.06
Fgg NM_133862.1 −2.36** −2.95** −1.25
Nr1h4 NM_009108.1 −2.33** −3.16* −1.35
Kng1 NM_023125.2 −2.32** −2.87** −1.24
Slc7a9 NM_021291.1 −2.28* −3.04* −1.34
Slc7a9 NM_021291.1 −2.27** −2.82* −1.24
Irf6 NM_016851.2 −2.25** −2.43* −1.08
Trf NM_133977.2 −2.19** −2.37** −1.08
Sema4a NM_013658.2 −2.16* −2.60* −1.20
Serpina1b NM_009244.4 −2.16** −2.62** −1.21
Gipc2 NM_016867.1 −2.15** −2.56* −1.19
Kng2 NM_201375.1 −2.15** −2.59* −1.20
Igfbp6 NM_008344.2 −2.06** −3.64* −1.76
Ostb NM_178933.2 −2.08** −1.83 1.14
Pmp22 NM_008885.2 −2.06* −1.98 1.04
Fbp2 NM_007994.3 −3.62** −2.27 1.59
Apoa4 NM_007468.2 −3.25** −3.06 1.06
Bex2 NM_009749.1 −3.19** −2.71 1.18
Eps8l3 NM_133867.1 −3.00** −2.13 1.40
Slc23a3 NM_194333.3 −2.92** −2.97 −1.02
Lbp NM_008489.2 −2.89** −2.39 1.21
Pdzk1ip1 NM_026018.2 −2.81** −2.62 1.07
Upk3b NM_175309.3 −2.78** −2.27 1.23
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qRT-PCR correlated with those of the microarray ana-
lysis. However, quantitative gene expression analysis in
individual placentas showed that the expression levels
varied over a wide range among the five SCNT placentas
from the normal placental state.
Discussion
This study was undertaken to profile gene expression in
the placentas of SCNT and aggregated SCNT and in vivo
fertilization placentas by microarray analysis. We ob-
tained a list of up- and down-regulated genes showing
Table 4 Comparison of the genes that were down-regulated (fold change) in SCNT placentas versus in aggregated SCNT placentas
(Continued)
Sepp1 NM_009155.3 −2.74** −2.60 1.06
Cyp2c70 NM_145499.1 −2.65** −2.28 1.16
Fmo1 NM_010231.2 −2.59** −2.44 1.06
Upk3b NM_175309.3 −2.43** −2.05 1.19
Rnase4 NM_201239 −2.32** −2.76 −1.19
Apoc1 NM_007469.3 −2.31* −2.07 1.11
Apoc1 NM_007469.3 −2.30* −2.07 1.11
Gpc3 NM_016697.2 −2.25* −2.23 1.01
Timd2 NM_134249.3 −2.16* −2.39 −1.11
Pcdh24 NM_001033364.2 −2.15** −2.29 −1.07
Gldc NM_138595.1 −2.12** −2.18 −1.03
Bglap-rs1 NM_031368.3 −2.03* −2.13 −1.05
Abcc10 NM_170680.2 −2.93** 1.01 2.96*
Prss22 NM_133731.1 −2.70** −1.11 2.44*
Significantly reduced in SCNT
*p < 0.05; **p < 0.01
Table 5 Imprinted gene expression








Atp10a NM_009728.1 1.22 1.25 Slc22a4 NM_019687.3 −1.11 1.35
Cdkn1c NM_009876.3 1.01 −1.02 Ube3a NM_011668.2 −1.05 −1.03
Dcn NM_007833.4 −1.56 −1.18 Zim1 NM_011769.3 −1.32 −1.27
Gnas NM_201617.1 −1.10 1.04 Slc38a4 NM_027052.3 2.32** 1.55
Meg1/Grb10 NM_010345 −1.75 −1.05 Cdkn1c NM_009876.3 1.01 −1.02
H19 NR_001592.1 1.02 1.10 Igfbp6 NM_008344.2 −3.64** −1.76
Igf2 NM_010514.2 −1.01 −1.02 Igfbp2 NM_008342.2 −1.65 1.29
Igf2r NM_010515.1 −1.35 −1.11 Xist NR_001463.2 1.24 1.03
Impact NM_008378.2 −1.20 1.04 Ppp1r9aa NM_181595.3 −1.44 −1.05
Ins1 NM_008386.3 −1.03 −1.01 Tssc4a NM_020285.1 1.06 −1.02
Ins2 NM_008387.3 1.26 1.10 Ascl2a NM_008554.2 1.81 1.52
Peg1/Mest NM_008590.1 −1.41 1.00 Cd81a NM_133655.1 −1.42 −1.18
Peg10 NM_001040611.1 1.10 1.07 Pon2a NM_183308.2 1.20 1.16
Peg3 NM_008817.2 −1.16 1.04 Slc22a2a NM_013667.2 −1.02 1.06
Rasgrf1 NM_011245.1 1.17 1.24
Ndn NM_010882.3 −1.23 −1.06
Nnat NM_010923.2 −1.62 1.13
Slc22a18 NM_008767.2 1.32 2.95*
Significantly reduced in SCNT
aPlacenta-specific imprinted genes in mice and human
*p < 0.05; **p < 0.01
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>2-fold difference between the SCNT and control pla-
centas. The number of upregulated genes was lower by
75% in the aggregated SCNT placentas than in the
SCNT placentas (206→ 52). The gene expression
profiles of aggregated SCNT placentas were more simi-
lar to those of controls than to the profiles of SCNT
placentas.
The data presented here indicate that the number of
differentially deregulated genes in the SCNT placentas
was decreased by 94.2% (85→ 5) in the aggregated
SCNT placentas. These results are consistent with those
of a direct comparison between gene expression in
cumulus and ES cells of SCNT placentas, where there
was a similar number of deregulated genes between both
cell types [13]. Inappropriate reprogramming frequently
occurs in somatic cell-cloned embryos [21], resulting in
various deregulated gene expression patterns and
epigenetic modifications in both the placenta and fetus
[13]. Thus, the differences in gene expression were
remarkably reduced by the aggregated SCNT method.
The majority of aberrantly expressed genes were com-
mon to placentas cloned with ES or cumulus cells [13].
This indicated that placentomegaly in cloned mice is in-
dependent of the nuclear source of donor cells [6, 22,
23]. Therefore, aggregation of the tetraploid embryos
utilized in this study have the key potential to reduce
aberrant gene expression during the production of
cloned mice, regardless of the nucleus source.
Many abnormalities in cloned animals suggest im-
printing disruptions [24]. Placentomegaly was observed
upon deregulation of imprinting genes such as H19 [12],
Esx1 [10], and Ipl [11]. Although H19 was shown to be
one of the variable genes among cloned animals, its
expression showed no variability in the presented micro-
array results, confirming previous results [13, 25]. It is
also reported that the expression of insulin-like growth
factor 2 receptor (Igf2r) was increased in placentomegaly
[26]. In the present study, Igf2r expression was margin-
ally reduced. Most of the identified imprinted genes
showed a decreased expression. These results indicate
that the decreased expression of those imprinted genes
is caused by reduced expression of the normally active
allele [25, 27]. However, only three genes Slc22a18,
Fig. 2 Quantitative real time PCR analysis. Twelve genes from different categories were chosen for qRT-PCR analyses. Eight genes were upregulated in
the SCNT placentas. The other three genes were upregulated in the control group. H19 showed almost the same expression pattern. The β-actin gene
was used as the endogenous control








Plac1 NM_019538.3 2.73** ↑NT 6.54
Slc38a4 NM_027052.3 2.32** ↑NT 4.04*
Rprml NM_001033212.1 3.25** ↑NT 4.51
Pla2g4f NM_001024145.1 4.10** ↑NT 3.13*
Pla2g4d NM_001024137.1 3.70** ↑NT 9.04
Hsd17b7 NM_010476.3 3.24** ↑NT 7.66
Hmox1 NM_010442.1 2.73** ↑NT 4.30
Chac1 NM_026929.3 −2.27* ↓NT −8.41
Car2 NM_009801.3 3.95** ↑NT 6.11
Slpi NM_011414.2 −4.56** ↓NT −4.06
Nrn1l NM_175024.3 −2.49** ↓NT −3.05**
H19 NR_001592.1 1.10 1.19
*Fold change values with superscripts were significantly different
*p < 0.05; **p < 0.01
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Slc38a4, and Igfbp6 were expressed differentially be-
tween both placentas of SCNT and control placentas.
In the “biological process” category, the largest num-
ber of deregulated genes represented signal transduction
(14%) proteins. In contrast, the largest number of genes
in the molecular function category remained unclassi-
fied. Thus, it was very difficult to identify the specific
causative genes of placentomegaly in SCNT placenta,
but the condition seems to be caused by multiple-gene
dysfunction. In the present study, we assessed differ-
ences in the expression of placenta-specific genes
between SCNT and controls by qRT-PCR. These differ-
ences in expression were confirmed for eight genes.
Plac1, a placenta-specific gene, is known to be expressed
exclusively by the cells of the trophoblastic lineage in
mice [28]. The other seven genes Slc38a4, Rprml,
Pla2g4f, Hsd17b7, Hmox1, Car2, and Pla2g4d were
specifically expressed in SCNT placentas. In the present
study, Plac1 is considered a candidate gene involved in
placentomegaly in NT placentas, as reported previously
[14]. Thus, these genes need to be systematically studied
to resolve placentomegaly.
The altered expression of hundreds of genes in SCNT
placentas may be related to the high mortality rate of
cloned embryos [13]. According to Miki et al. [19], the
extraembryonic lineages could be composed of tetraploid
cells, the population of which was increased in full-term
placental tissues. Specifically, tetraploid chimeras are con-
sidered the most outstanding result, since they enable the
production of whole stem cell-derived mice offspring,
whereas offspring could not be produced using the inner
cell mass and pluripotent cells in chimeric rhesus
monkeys [20, 29]. In the present study, our results are
consistent with those of previous reports indicating that
most clones show gene expression abnormalities resulting
in subtle phenotype changes [30, 31], premature death
[32], placental hyperplasia [19], or obesity [33].
These results are thought to be caused by aggregation
of tetraploid embryos leading to the recovery of down-
regulated gene expression in the SCNT placentas.
Conclusions
In summary, we present list of up- and down-regulated
genes in the two types of SCNT and in vivo fertilization
placentas. The expression of 206 (1.6%) of the 12,816
genes was found to be different by at least 2-fold be-
tween the SCNT placentas and controls. Further, 159
genes showed differential expression between the SCNT
placentas and the aggregated SCNT placentas. However,
gene expression profiles of the aggregated SCNT placen-
tas were more similar to those of the controls than to
those of the SCNT placentas. These results indicate that
the aggregation SCNT technique using tetraploid em-
bryos considerably decreased the number of deregulated
genes by 94.2% (85→ 5) in the SCNT placentas. There-
fore, aggregation with tetraploid embryos reduced
abnormal gene expression in a genome-wide manner in
the cloned placentas. Further studies will be needed to
outline the molecular and functional mechanisms under-
lying abnormal expression of placenta-specific genes
derived from tetraploid and cloned embryos.
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